Cardiovascular Rounds

News, resources, and analysis from the Cardiovascular Roundtable

Filtered by: Service Lines Hide

How to address PACT—a hidden threat to your TAVR margins

by Megan Tooley and Marissa (Schwartz) Schaffer August 10, 2017

Facing challenging TAVR finances? You're not alone. In addition to device, infrastructure, and operating costs, it turns out that an often-overlooked CMS policy may be eating away at your margins–but that doesn't have to be the case.

Read more »

From risk factors to Apple apps: 4 major trends in the arrhythmia world

by Megan Tooley and Julie Bass June 1, 2017

Patients with atrial fibrillation (AF) and other cardiac arrhythmias are particularly complex to manage due to the chronic, often comorbid nature of these patient populations. Heart rhythm disorders affect patients both within and outside the CV service line—in fact, 17% of all admitted patients in the United States have some type of arrhythmia.

But that's not the most concerning point: The prevalence of atrial fibrillation (AF) is expected to grow to 12.1 million by 2030, more than double the 5.1 million cases in 2010.

Read more »

Why there's new urgency for CV programs to consider social determinants of health

by Megan Tooley and Emily Snow May 16, 2017

For the most part, CMS's FY 2018 Inpatient Prospective Payment System (IPPS) proposed rule includes nothing unexpected for CV leaders. However, it does address one highly debated topic—socioeconomic status (SES) as it relates to pay-for-performance programs.

Some critics of the these programs have taken issue with their failure to account for SES, out of a concern that providers who serve low-SES populations with significant health risk factors may incur penalties at a disproportionate rate.

This is of particular concern for cardiovascular service lines, as there is a strong link between cardiovascular disease and social determinants. Additionally, cardiovascular programs have an increasing amount of their business tied to cross-continuum care through pay-for-performance programs such as the Hospital Readmissions Reduction Program (HRRP), in which reimbursement dollars are tied to what happens to patients after they leave the hospital.

Read more »

The FY 2018 Inpatient Proposed Rule: Early insights for CV leaders

Megan Tooley April 21, 2017

April showers bring May flowers and—this year, at least—CMS's FY 2018 Inpatient Prospective Payment System (IPPS) proposed rule. Per usual, this rule outlines CMS's proposed updates to inpatient reimbursement for acute and long term care hospitals as well as changes to policy and quality reporting requirements for these providers. If approved, these changes will go into effect on October 1, 2017.

Read more »

How to increase radial access—and potentially save $1M per year

by Megan Tooley and Marissa Schwartz March 22, 2017

Over the past several years, there's been mounting evidence that radial access is superior to femoral access when it comes to percutaneous coronary intervention (PCI). But despite its benefits, many programs still struggle with radial access adoption. Read on for best practice strategies to improve radial access rates. 

Read more »

What you need to know about 3 new cardiovascular guidelines

by Marissa Schwartz and Catherine Kosse March 8, 2017

With all of the emails coming into your inbox as a CV leader, it can be easy to overlook the most relevant clinical guidelines from CV-related societies. But it's important to stay abreast of these changes to ensure your CV program uses the most progressive treatments possible.

Read more »

How a 'Novel' approach can make your anticoagulation clinic more important than ever

by Daniel Roza February 22, 2017

Novel Oral Anticoagulants (NOACs) have been receiving increasing attention as alternatives to warfarin in mitigating stroke risk for atrial fibrillation (AF) patients. These drugs may pose a threat to the over 3,000 anticoagulation clinics across the country that base their business on the maintenance and management of warfarin treatments.

But NOACs are far from an excuse to close up shop—instead, their rise can be seen as an opportunity for anticoagulation clinics to cement their foundational role as a center for care management.

Read more »

What's changed with TAVR? 4 takeaways from the TVT Registry Report

by Marissa Schwartz February 8, 2017

Transcatheter aortic valve replacement (TAVR) and structural heart services remain a key priority for many CV programs—particularly as recent clinical and regulatory changes have driven significant growth and expansion of the eligible patient population.

Amidst these exciting and rapidly shifting dynamics, a new report from the STS/ACC Transcatheter Valve Therapy (TVT) Registry paints a clear picture of TAVR in real world use.  

Read more »

Comment Now

You must be logged in to comment

What Your Peers Are Saying

Rating: | Brian Maher | March 30, 2012